Syros Pharmaceuticals Inc. (SYRS)
followers
ยท
Follow
Sector: | HEALTH CARE |
Industry: | PHARMACEUTICALS |
SIC: | PHARMACEUTICAL PREPARATIONS |
CEO: | Nancy A. Simonian |
Employees: | 120 |
Web site: | syros.com |
35 CAMBRIDGE PARK DRIVE, CAMBRIDGE, MA, 02140
617-744-1340
|
Date | Ratio |
---|---|
2022-09-19 | 1:10 |
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|
Syros Pharmaceuticals, Inc. focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset of patients with myelodysplastic syndrome.
Please log in first to see chart